Appointed
Joseph Levin
Director
WBD ·
Warner Bros. Discovery, Inc.
Mr. Levin’s election will be effective as of February 1, 2025
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5601–5650 of 35158
Mr. Levin’s election will be effective as of February 1, 2025
Mr. Noto’s election was effective as of January 8, 2025
On January 7, 2025, Janet Rehnquist resigned as a member of the Board of Directors (“ Board ”) of NRx Pharmaceuticals, Inc. (the “ Company ”), effective immediately.
the Board of Directors (the “Board”) of the Company appointed Phillip Balatsos, Mohsen (Michael) Khorassani and Andrew Hancox as new members of the Board
the Board accepted the resignation letters previously tendered by existing members of the Board, Debra Smith, Robert C. Oakes, Reid S. Holbrook, Brett Chugg and Ernest M. (Kiki) VanDeWeghe
the Board accepted the resignation letters previously tendered by existing members of the Board, Debra Smith, Robert C. Oakes, Reid S. Holbrook, Brett Chugg and Ernest M. (Kiki) VanDeWeghe
the Board accepted the resignation letters previously tendered by existing members of the Board, Debra Smith, Robert C. Oakes, Reid S. Holbrook, Brett Chugg and Ernest M. (Kiki) VanDeWeghe
the Board accepted the resignation letters previously tendered by existing members of the Board, Debra Smith, Robert C. Oakes, Reid S. Holbrook, Brett Chugg and Ernest M. (Kiki) VanDeWeghe
the Board of Directors (the “Board”) of the Company appointed Phillip Balatsos, Mohsen (Michael) Khorassani and Andrew Hancox as new members of the Board
the Board accepted the resignation letters previously tendered by existing members of the Board, Debra Smith, Robert C. Oakes, Reid S. Holbrook, Brett Chugg and Ernest M. (Kiki) VanDeWeghe
the Board of Directors (the “Board”) of the Company appointed Phillip Balatsos, Mohsen (Michael) Khorassani and Andrew Hancox as new members of the Board
On January 14, 2025, Irakli Tatarishvili and Giorgi Sambadze submitted their resignation from their director positions with the Company effective immediately.
On January 14, 2025, Irakli Tatarishvili and Giorgi Sambadze submitted their resignation from their director positions with the Company effective immediately.
On January 9, 2025, Warner H. Session was appointed as an independent director of Capstone Companies, Inc.
On January 13, 2025, the Board of Directors of Wheeler Real Estate Investment Trust, Inc. ("WHLR"), the sole common stockholder of Cedar Realty Trust, Inc. (the "Company"), voted to elect Gary Skoien as a director of the Company, to serve effective immediately until the next annual meeting of the Company’s sole common stockholder or until his successor is duly elected and qualified, or until his earlier death, resignation or removal.
the board of directors of Tactile Systems Technology, Inc. (the “Company”) elected Laura G. King to serve as a member of the board and fixed the size of the board at nine directors, all effective as of January 13, 2025.
On January 10, 2025, Alan Liu and Luis Sosa each submitted a letter to the Board of Directors of Vacasa, Inc. (the “Company”), submitting their respective resignations as a director of the Company, effective immediately.
On January 10, 2025, Alan Liu and Luis Sosa each submitted a letter to the Board of Directors of Vacasa, Inc. (the “Company”), submitting their respective resignations as a director of the Company, effective immediately.
On January 8, 2025, the Board of Directors (the “Board”) of the Company, upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Keli Walbert to the Board as a Class II director to serve until the Annual Meeting of Stockholders to be held in 2025 or until her successor has been duly elected and qualified or until her earlier death, resignation or removal.
On January 9, 2025, James Champy informed the Board of Directors (the “Board”) of Analog Devices, Inc. (the “Company”) that he had decided to retire from the Board and not to stand for re-election at the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”) to be held on March 12, 2025.
On January 9, 2025, the Board increased the size of the Board to twelve members and appointed Andrea F. Wainer as an independent director, effective as of the same day
On January 6, 2025, Andrew N. Shapiro resigned from the Board of Directors (the “Board”) and all Board committee positions of The GEO Group, Inc. (“GEO” or the “Company”) effective as of January 6, 2025 for personal reasons.
elected Joe Taylor as a Class I independent director of the Company, effective January 13, 2025.
On January 6, 2025, the Board of Directors (the “Board”) of Ondas Holdings Inc. (the “Company” or “Ondas”) appointed Ron Stern as a director of the Company, effective January 7, 2025.
On January 8, 2025, Ned Siegel notified the Board of Directors (“Board”) of Vocodia Holdings Corp. (the “Company”) of his resignation as a director of the Company and member of each committee of the Board, effective January 8, 2025.
On January 13, 2025, the Board of Directors (the “Board”) of Nxu, Inc. (the “Company”) elected Erin Essenmacher to serve as a director on the Board, effective immediately, to fill the vacancy on the Board.
the Board of Directors (the "Board") elected Sonya C. Little, former Executive Vice President, Chief Administrative Officer of Strategic Property Partners LLC, and Kathleen M. Shanahan, Senior Advisor and former Chief Executive Officer of Turtle & Hughes, Inc., to serve as a director of the Company
the Board of Directors (the "Board") elected Sonya C. Little, former Executive Vice President, Chief Administrative Officer of Strategic Property Partners LLC, and Kathleen M. Shanahan, Senior Advisor and former Chief Executive Officer of Turtle & Hughes, Inc., to serve as a director of the Company
On January 8, 2025, the Board of Directors (the "Board") of Windtree Therapeutics, Inc. (the "Company") approved an increase in the number of directors on the Board to five and appointed Leanne Kelly as a director and member and chair of the Audit Committee, effective immediately.
On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.
LAS VEGAS, NV— January 10, 2025 – Crown Equity Holdings, Inc. (OTCPINK: CRWE) announced today that effective immediately, the Company has accepted the resignation of its Board Member and Marketing/Merger and Acquisition Officer, Jamie Hadfield.
On January 7, 2025, Mr. Wm. Ronald Duffey notified us that he will be retiring from our board of directors at our annual member meeting on March 31, 2025.
On January 12, 2025, the Board of Directors (the “Board”) of SLM Corporation (the “Company”) appointed Henry F. Greig as a director of the Company, effective January 12, 2025.
On January 10, 2025, Richard Berman gave notice of his resignation from the Board of Directors (the “Board”) of Context Therapeutics Inc. (the "Company"), effective as of January 12, 2025.
On January 10, 2025, the Board appointed Mr. Shivaram as a Class III director of the Board, effective January 10, 2025
Timothy K. Flanagan, a Class I director, submitted his resignation from the Board, effective immediately, and was immediately reappointed to the Board as a Class II director
On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.
On January 6, 2025, Dr. Vaughn Himes informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that he has elected to resign from his position as a member of the Board, effective immediately.
On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.
On January 9, 2025, Ronald S. Lauder, a member of the Board of Directors (the “Board”) of The Estée Lauder Companies Inc. (the “Company”), notified the Company that he will retire from the Board, effective January 10, 2025.
Eric Zinterhofer, 53, has been elected by the Board as a Class II director, as Mr. R. Lauder’s designee under the Stockholders’ Agreement.
Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025
On January 9, 2025, Sara Mathew notified Carnival Corporation and Carnival plc (together, the “Company”) that she has made the decision not to stand for re-election at the 2025 Annual Meetings of Shareholders to allow her to focus on her other business ventures.
On January 3, 2025, Robert McBey resigned as a director of AtlasClear Holdings, Inc.
On January 7, 2025, the Board of Directors (the “Board”) of Enzon Pharmaceuticals, Inc. (the “Company”) approved an increase in the number of directors on the Board to four and appointed Stephen T. Wills as a director, effective immediately.
On January 9, 2025, the Board of Directors (the “Board”) of Annexon, Inc. (the “Company”) appointed William Jones, to the Board, effectively immediately.
On January 3, 2025, the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors effective immediately.
On January 3, 2025, the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors effective immediately.
On January 6, 2025, Michael A. Havard a member of the Board of Directors of Stellar Bancorp, Inc. (the “Company”) provided notice of his decision to not stand for reelection at the Company’s 2025 Annual Shareholder’s Meeting
On January 7, 2025, the board of directors (the "Board") approved the appointment of Mr. Christopher John Regan as an independent director of the Company, effective on the same date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.